BioCentury
ARTICLE | Financial News

Sofinnova raises $500 million for ninth fund

July 24, 2014 12:58 AM UTC

Sofinnova Ventures raised $500 million for Sofinnova Venture Partners IX, its ninth fund and second life sciences-only fund. The firm was targeting $425 million for the fund, which was oversubscribed. Sofinnova plans to invest the fund in 20-22 therapeutics companies primarily in the U.S. but also in Europe. The firm said it will invest the fund in companies developing specialty pharmaceuticals and Orphan disease products. ...